BR100 Increased By (0.05%)
BR30 Increased By (0.49%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.39%)
AGHA 6.44 Increased By ▲ 0.12 (1.9%)
BECO 4.36 Increased By ▲ 0.09 (2.11%)
BML 62.50 Increased By ▲ 0.05 (0.08%)
BOP 31.45 Increased By ▲ 0.22 (0.7%)
CNERGY 11.67 Increased By ▲ 0.08 (0.69%)
CSIL 5.86 Increased By ▲ 0.14 (2.45%)
FCCL 60.75 Decreased By ▼ -0.79 (-1.28%)
FFL 14.70 Decreased By ▼ -0.32 (-2.13%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.91 Increased By ▲ 0.35 (6.29%)
LOTCHEM 24.80 Increased By ▲ 0.12 (0.49%)
MLCF 102.96 Decreased By ▼ -1.12 (-1.08%)
NBP 172.95 Decreased By ▼ -2.33 (-1.33%)
NCPL 52.47 Decreased By ▼ -0.30 (-0.57%)
NPL 53.95 Decreased By ▼ -0.17 (-0.31%)
OGDC 317.16 Increased By ▲ 3.77 (1.2%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.62 Decreased By ▼ -0.18 (-0.5%)
PIBTL 13.69 Increased By ▲ 0.22 (1.63%)
PPL 226.52 Increased By ▲ 4.71 (2.12%)
PRL 80.50 Increased By ▲ 1.42 (1.8%)
PTC 46.87 Increased By ▲ 0.02 (0.04%)
SSGC 23.84 Decreased By ▼ -0.03 (-0.13%)
TBL 9.29 Decreased By ▼ -0.02 (-0.21%)
TELE 7.58 Increased By ▲ 0.19 (2.57%)
TPL 24.61 Decreased By ▼ -0.50 (-1.99%)
TPLP 12.85 Increased By ▲ 0.34 (2.72%)
TREET 25.89 Decreased By ▼ -0.36 (-1.37%)
TRG 53.35 Decreased By ▼ -0.09 (-0.17%)
World

Swiss say Pfizer/Biontech will deliver 3 million doses of vaccine

  • With two doses likely to be necessary, the contract means one and half million people in the country could be vaccinated, the government added in a statement.
Published Updated
By

ZURICH: Switzerland has signed a contract with Pfizer and BioNTech to deliver 3 million doses of their coronavirus vaccine, the government said on Monday.

With two doses likely to be necessary, the contract means one and half million people in the country could be vaccinated, the government added in a statement.

Switzerland has also signed agreements with two other vaccine manufacturers - Moderna and AstraZeneca.

All three vaccines are undergoing the approval process by SwissMedic.

Comments

Comments are closed for this article.